Article: Juvenile polyposis syndrome

Juvenile polyposis syndrome (JPS) patients can have a significantly high burden of polyposis. Patient who undergoes prophylactic colectomy for polyps not amenable to endoscopic treatments requires close clinical surveillance to negate risk of malignancy from interval polyposis.

Citing Articles

Phenotypic characterisation of variant carriers.

Caillot C, Saurin J, Hervieu V, Faoucher M, Reversat J, Decullier E J Med Genet. 2024; 61(8):734-740.

PMID: 38575304 PMC: 11287639. DOI: 10.1136/jmg-2023-109632.

Juvenile Polyposis Syndrome Complicated With Gastric Outlet Obstruction.

Rios Crespo R, Currais P, Craciun A, Sobral Dias M, Lopes J, Cabral Braga T ACG Case Rep J. 2022; 9(11):e00886.

PMID: 36382332 PMC: 9663133. DOI: 10.14309/crj.0000000000000886.

Sirolimus for the Treatment of Juvenile Polyposis in Childhood.

Martin-Masot R, Cardelo Autero N, Ortiz Perez P, Torcuato Rubio E, Vazquez Pedreno L, Gallego Fernandez C ACG Case Rep J. 2021; 8(8):e00646.

PMID: 34476273 PMC: 8389908. DOI: 10.14309/crj.0000000000000646.

Juvenile polyposis syndrome.

Hussain T, Church J Clin Case Rep. 2020; 8(1):92-95.

PMID: 31998494 PMC: 6982494. DOI: 10.1002/ccr3.2616.

References

1.

Howe J, Roth S, Ringold J, Summers R, Jarvinen H, Sistonen P . Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science. 1998; 280(5366):1086-8. DOI: 10.1126/science.280.5366.1086. View

2.

Aytac E, Sulu B, Heald B, OMalley M, LaGuardia L, Remzi F . Genotype-defined cancer risk in juvenile polyposis syndrome. Br J Surg. 2014; 102(1):114-8. DOI: 10.1002/bjs.9693. View

3.

Aretz S, Stienen D, Uhlhaas S, Stolte M, Entius M, Loff S . High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome. J Med Genet. 2007; 44(11):702-9. PMC: 2752176. DOI: 10.1136/jmg.2007.052506. View

4.

Ngeow J, Heald B, Rybicki L, Orloff M, Chen J, Liu X . Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polyps. Gastroenterology. 2013; 144(7):1402-9, 1409.e1-5. PMC: 3969031. DOI: 10.1053/j.gastro.2013.02.001. View

5.

OMalley M, LaGuardia L, Kalady M, Parambil J, Heald B, Eng C . The prevalence of hereditary hemorrhagic telangiectasia in juvenile polyposis syndrome. Dis Colon Rectum. 2012; 55(8):886-92. DOI: 10.1097/DCR.0b013e31825aad32. View

6.

Latchford A, Neale K, Phillips R, Clark S . Juvenile polyposis syndrome: a study of genotype, phenotype, and long-term outcome. Dis Colon Rectum. 2012; 55(10):1038-43. DOI: 10.1097/DCR.0b013e31826278b3. View

7.

Dove-Edwin I, Sasieni P, Adams J, Thomas H . Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ. 2005; 331(7524):1047. PMC: 1283179. DOI: 10.1136/bmj.38606.794560.EB. View

8.

Brosens L, van Hattem A, Hylind L, Iacobuzio-Donahue C, Romans K, Axilbund J . Risk of colorectal cancer in juvenile polyposis. Gut. 2007; 56(7):965-7. PMC: 1994351. DOI: 10.1136/gut.2006.116913. View

9.

Hussain T, Church J . Juvenile polyposis syndrome. Clin Case Rep. 2020; 8(1):92-95. PMC: 6982494. DOI: 10.1002/ccr3.2616. View

10.

Wain K, Ellingson M, McDonald J, Gammon A, Roberts M, Pichurin P . Appreciating the broad clinical features of SMAD4 mutation carriers: a multicenter chart review. Genet Med. 2014; 16(8):588-93. PMC: 4125531. DOI: 10.1038/gim.2014.5. View

11.

Syngal S, Brand R, Church J, Giardiello F, Hampel H, Burt R . ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015; 110(2):223-62. PMC: 4695986. DOI: 10.1038/ajg.2014.435. View